GLP-1 drugs like Mounjaro, which were created to help type 2 diabetes patients and sometimes manage weight loss, actually ...

A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The ...

A Labcorp team member draws blood from a patient.Labcorp Labcorp, one of the country’s largest providers of diagnostic ...

Welcome to this week’s Food Exec Brief, a roundup of the most important news shaping food and beverage manufacturing, from ...

Type 1 diabetes was linked to increased risk for dementia, especially vascular dementia, non-Alzheimer-nonvascular dementia, and Alzheimer disease.

Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...

Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...

Neurologist Dr. Gavin Brown describes Parkinson’s disease as one of the most common neurodegenerative conditions, second only ...

Get the latest on Novo Nordisk's Alzheimer's trial, stock outlook, and market risks. See what investors need to know before ...

People without diabetes who receive GLP-1 receptor agonists for the treatment of overweight or obesity face a reduced risk of ...

Researchers at the University of California, Irvine, have uncovered an unexpected molecular partnership that reshapes ...

Researchers at the University of California, Irvine, have uncovered an unexpected molecular partnership that reshapes scientists' understanding of how brain inflammation arises in Alzheimer's disease.